AU6835996A - Pyridinium derivatives and pharmaceutical compositions containing them - Google Patents
Pyridinium derivatives and pharmaceutical compositions containing themInfo
- Publication number
- AU6835996A AU6835996A AU68359/96A AU6835996A AU6835996A AU 6835996 A AU6835996 A AU 6835996A AU 68359/96 A AU68359/96 A AU 68359/96A AU 6835996 A AU6835996 A AU 6835996A AU 6835996 A AU6835996 A AU 6835996A
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- pyridinium derivatives
- pyridinium
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/559—Redox delivery systems, e.g. dihydropyridine pyridinium salt redox systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL11511395A IL115113A (en) | 1995-08-31 | 1995-08-31 | 3-carbamoyloxy pyridinium derivatives and pharmaceutical compositions containing them |
IL115113 | 1995-08-31 | ||
PCT/IL1996/000089 WO1997008146A1 (en) | 1995-08-31 | 1996-08-29 | Pyridinium derivatives and pharmaceutical compositions containing them |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU61228/00A Division AU6122800A (en) | 1995-08-31 | 2000-09-21 | Pyridinium derivatives and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6835996A true AU6835996A (en) | 1997-03-19 |
Family
ID=11067933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU68359/96A Abandoned AU6835996A (en) | 1995-08-31 | 1996-08-29 | Pyridinium derivatives and pharmaceutical compositions containing them |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0851859A1 (en) |
JP (1) | JPH11511456A (en) |
AU (1) | AU6835996A (en) |
CA (1) | CA2230578A1 (en) |
IL (1) | IL115113A (en) |
WO (1) | WO1997008146A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE990286A1 (en) * | 1999-04-07 | 2000-11-01 | Malope Company Ltd | Diagnosis of irritable bowel syndrome based on demonstrated central cholinergic supersensitivity. |
FR2795412B1 (en) * | 1999-06-23 | 2001-07-13 | Adir | NOVEL QUATERNARY AMMONIUM DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
CA2448317A1 (en) * | 2001-05-30 | 2002-12-05 | Alteon Inc. | Method for treating glaucoma v |
CA2603345C (en) | 2005-04-01 | 2017-05-02 | Insa Rouen | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
EP1731507A1 (en) * | 2005-04-26 | 2006-12-13 | Institut National des Sciences Appliquees de Rouen (INSA) | New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents |
WO2011100373A1 (en) | 2010-02-09 | 2011-08-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
US8946261B2 (en) | 2011-02-14 | 2015-02-03 | Council Of Scientific & Industrial Research | Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease |
US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
EP2759536A1 (en) | 2013-01-25 | 2014-07-30 | INSA (Institut National des Sciences Appliquees) de Rouen | Oxidisable pyridine derivatives, their preparation and use as anti-Alzheimer agents |
EP3827820A1 (en) | 2013-03-15 | 2021-06-02 | The Johns Hopkins University | Brivaracetam for improving cognitive function |
JP6433482B2 (en) | 2013-03-15 | 2018-12-05 | エージンバイオ, インコーポレイテッド | Methods and compositions for improving cognitive function |
GR1008233B (en) * | 2013-03-28 | 2014-06-23 | Αλεξανδρος Δημητριου Βαμβακιδης | Optimization and therapeutic valorization of the symptomatic treatment of alzheimer's disease with rivastigmine, galantamine or donepezil, by selected aminotetrafurans acting as mixed sigma-1 / muscarinic ligands |
WO2016191288A1 (en) | 2015-05-22 | 2016-12-01 | Agenebio, Inc. | Extended release pharmaceutical compositions of levetiracetam |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2839536A (en) * | 1958-06-17 | Salts of disubstituted carbamic acid | ||
FR2517307A1 (en) * | 1981-11-27 | 1983-06-03 | France Etat | Alkyl imidazolium di:methyl carbamoyl pyridinium double salts - for prevention of phosphorus pesticide intoxication |
IT1169873B (en) * | 1983-10-21 | 1987-06-03 | Prodotti Formenti Srl | PHARMACEUTICAL COMPOSITION WITH SYSTEMIC ANTI-COLINESTERASIC, AGONISTIC-COLINERGIC AND ANTI-MUSCARINIC ACTIVITY |
-
1995
- 1995-08-31 IL IL11511395A patent/IL115113A/en not_active IP Right Cessation
-
1996
- 1996-08-29 CA CA002230578A patent/CA2230578A1/en not_active Abandoned
- 1996-08-29 AU AU68359/96A patent/AU6835996A/en not_active Abandoned
- 1996-08-29 JP JP9510076A patent/JPH11511456A/en active Pending
- 1996-08-29 EP EP96928661A patent/EP0851859A1/en not_active Withdrawn
- 1996-08-29 WO PCT/IL1996/000089 patent/WO1997008146A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL115113A (en) | 2002-11-10 |
EP0851859A1 (en) | 1998-07-08 |
IL115113A0 (en) | 1995-12-08 |
WO1997008146A1 (en) | 1997-03-06 |
CA2230578A1 (en) | 1997-03-06 |
JPH11511456A (en) | 1999-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL116851A (en) | 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them | |
AU6613996A (en) | Heterocyclic compounds and pharmaceutical compositions containing them | |
IL116917A (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
AU6216296A (en) | Pharmaceutical compositions | |
AU6232096A (en) | Aromatic compounds and pharmaceutical compositions containing them | |
HUP0000474A3 (en) | Arylethenesulfonamide derivatives and drug composition containing the same | |
AU6418596A (en) | Compounds and pharmaceutical compositions containing them | |
AU6232196A (en) | Aromatic compounds and pharmaceutical compositions containing them | |
IL119559A0 (en) | Purin -6- one derivatives their preparation and pharmaceutical compositions containing them | |
AU7590096A (en) | Drug composition | |
AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
HUP9802290A3 (en) | Pyrrole derivatives and pharmaceutical compositions containing them | |
ZA967800B (en) | Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them | |
HUP9801386A3 (en) | Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them | |
AU6835996A (en) | Pyridinium derivatives and pharmaceutical compositions containing them | |
HUP9602196A2 (en) | Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof | |
AU5155096A (en) | Pharmaceutical composition | |
AU6753298A (en) | Novel pyridine derivatives and pharmaceutical compositions containing them | |
AU5274096A (en) | Pharmaceutical compositions | |
AU7275894A (en) | Imidazolylalkylamine derivative and pharmaceutical composition thereof | |
AU3806595A (en) | Benzisoxazole derivatives and pesticidal compositions containing them | |
HUP9802291A3 (en) | Penicillaminamide derivatives and pharmaceutical compositions containing them | |
AU3710695A (en) | Quinolonylcarboxyerythromycin derivatives and pharmaceutical compositions containing them | |
AU5774796A (en) | Pharmaceutical compositions containing lornoxicam and cyclod extrin | |
AU6690394A (en) | Imidazolylquinoxalinedione derivative and pharmaceutical composition thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |